Chardan Capital Markets
Finance · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
17 State St Ste 2100, New York City, New...Phone Number
(646) 465-9000Website
www.chardan.comRevenue
$36.1 MillionIndustry
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
3
3
3
3
About Chardan Capital Markets
Chardan is an independent, full-service, global investment bank focused on bringing disruptive innovation to corporate and institutional clients. Chardan Capital Markets is headquartered in NYC, New York.Explore more
Chardan Capital Markets Org Chart
AW
Head Managing Director, Co- Fintech Investmen...
GB
Managing Director, Investment Banking
JR
Managing Director
DB
Managing Director
YW
Managing Director, Investment Banking
KB
Investment Banking Vice President, Healthcare
VD
Vice President, Investment Banking
MH
Vice President, Investment Banking
JT
Fintech Investment Banking Vice President, Te...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chardan Capital Markets your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Chardan Capital Markets
Website visits: Recent activity has been detected on your website
Chardan Capital Markets, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Chardan Capital Markets launches new products
Click to see if Chardan Capital Markets had a recent Job posting/layoffs
Check if Chardan Capital Markets has recently received funding, and reach out quickly before it becomes old news!
Check out if Chardan Capital Markets is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Chardan Capital Markets has new funding data
Earning: See what the market has to say on Chardan Capital Markets recently announced quarterly report
Recommended Actions
Find VP level buyers at Chardan Capital Markets
Find 2 more new buyers
Compare Similar Companies to Chardan Capital Markets
Compare insights from companies similar to Chardan Capital Markets, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Chardan Capital Markets is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Chardan Capital Markets is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Chardan Capital Markets.
Chardan Capital Markets financials insights
Gather financial insights about Chardan Capital Markets, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Chardan Capital Markets Tech Stack
A closer look at the technologies used by Chardan Capital Markets
See more technologies
Most Recent Scoops
Person-Based
Hiring Plans
Chardan Capital Markets has more open roles in Legal than it has had at any time in the past 12 months. Areas of expertise include: Dispute Resolution.
Hiring Plans
Project
Asset Management, Sales, Finance
Project
Asset Management, Sales, Finance
Project
Asset Management, Sales, Finance
Chardan Capital Markets News & Media
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced that Chad Cowan, Ph.D., Chief Scientific Officer of Century Therapeutics, will present at Chardan’s 9th Annual Genetic Medicines Conference on Tuesday, October 21, 2025, at 12:20 p.m. ET in New York, NY.Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings
NEW YORK, June 18, 2025 /PRNewswire/ -- Chardan, a leading global investment banking and advisory firm, today announced an expansion into the digital asset sector, advising on and structuring a series of transactions that bridge traditional capital markets with the rapidly evolving world...Klotho Neurosciences Raises $11M, Achieves Zero Debt and NASDAQ Compliance
Fresh capital injection strengthens Klotho's balance sheet as biotech firm clears debt and meets NASDAQ requirements. See detailed financial transformation.Chardan Acts as Financial Advisor in SPAC Takeover
NEW YORK, Feb. 26, 2024 /PRNewswire/ -- Chardan, a global investment bank, has announced that it has acted as financial advisor to Blufire Capital in connection with the Purchase and Sponsor Handover Agreement between Blufire Capital and Eve Mobility Acquisition Corp. "SPAC takeovers can...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Chardan Capital Markets
Sign Up For FreeTo access detailed company insights
Chardan is an independent, full-service, global investment bank focused on bringing disruptive innovation to corporate and institutional clients. Chardan Capital Markets is headquartered in NYC, New York.... Read More
